Genmab A/S (GMAB) Earnings Date and Reports 2024 - MarketBeat

2 days ago · View the latest GMAB earnings date, analysts forecasts, earnings history, and conference call transcripts. ... Genmab A/S posted Q3 2024 earnings on November 6, 2024, reporting an EPS of $0.29, ... The conference call transcript for Genmab A/S's latest earnings …

CouponFollow Extension

$0.29
OFF

Genmab A/S (GMAB) Earnings Date And Reports 2024 - MarketBeat

1 week from now

marketbeat.com

$0.22
OFF

Genmab A/S (GMAB) Set To Announce Quarterly Earnings On

1 week from now

Oct 30, 2024 · Genmab A/S (NASDAQ:GMAB - Get Free Report) last issued its earnings results on Thursday, August 8th. The company reported $0.22 earnings per share (EPS) for the …

marketbeat.com

$0.32
OFF

What Date Does Genmab's (GMAB) Report Earnings - Earnings …

1 week from now

Look out for GMAB's next earnings release on November 06, 2024. For the next earning release, we expect the company to report earnings of $0.32 per share, reflecting a year-over-year …

zacks.com

29%
OFF

Genmab AS (GMAB) Q3 2024 Earnings Call Highlights: Strong …

1 week from now

Nov 7, 2024 · Genmab AS (GMAB) reports a 29% revenue increase and strategic moves in its product pipeline, despite challenges in early-stage programs.

yahoo.com

$779
OFF

Genmab (NASDAQ:GMAB) Stock, Earnings Estimates, EPS, And …

1 week from now

A. The Actual Revenue was $779.5M, which beat the estimate of $733.2M. Browse earnings estimates, EPS, and revenue on all stocks. Genmab reports earnings on a quarterly basis. …

benzinga.com

$21.18
OFF

Genmab A/S (GMAB) Stock Earnings Dates & Report - Seeking Alpha

1 week from now

Genmab A/S (GMAB) latest earnings report: revenue, EPS, surprise, history, news and analysis. ... Earnings Date & History. Follow $21.18-0.48 ... Earnings history by period FQ3 2024 (Sep …

seekingalpha.com

5%
OFF

Genmab A Earnings Dates, Reports, Calls 2014-2024 (NASDAQ: …

1 week from now

The latest GMAB earnings report on Jun 30, 2024 announced Q2 2024 earnings of $202.3M, up 5.5% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, GMAB …

wallstreetzen.com

$22.64
OFF

Genmab A/S - ADR (GMAB) Price & News - Google Finance

1 week from now

The range between the high and low prices over the past day. $22.64 - $22.97. Year range. The range between the high and low prices over the past 52 weeks. $21.90 - $32.89. Market cap. …

google.com

$1.27
OFF

Q3 Earnings Forecast For Genmab A/S Issued By HC Wainwright

1 week from now

Oct 21, 2024 · The consensus estimate for Genmab A/S's current full-year earnings is $1.27 per share. HC Wainwright also issued estimates for Genmab A/S's FY2024 earnings at $1.36 …

marketbeat.com

$932000
OFF

Crossmark Global Holdings Inc. Has $932,000 Stake In

1 week from now

2 days ago · Genmab A/S has a 1 year low of $21.17 and a 1 year high of $32.89. Genmab A/S (NASDAQ:GMAB - Get Free Report) last announced its quarterly earnings results on …

marketbeat.com

$1.40
OFF

Ultragenyx Pharmaceutical (RARE) Earnings Date And Reports 2024

1 week from now

4 days ago · Ultragenyx Pharmaceutical issued Q3 2024 earnings on November 5, 2024, reporting an EPS of -$1.40, which topped the consensus estimate of -$1.45 by $0.05. …

marketbeat.com

$0.94
OFF

Revolution Medicines (RVMD) Earnings Date And Reports 2024

1 week from now

2 days ago · Revolution Medicines announced Q3 2024 earnings on November 6, 2024, reporting an EPS of -$0.94, which missed analysts' consensus estimates of -$0.89 by $0.05. With a …

marketbeat.com

FAQs about Genmab A/S (GMAB) Earnings Date and Reports 2024 - MarketBeat Coupon?

How did Genmab A/S's Stock perform in 2024?

Genmab A/S's stock was trading at $31.84 on January 1st, 2024. Since then, GMAB shares have decreased by 12.7% and is now trading at $27.80. View the best growth stocks for 2024 here. How were Genmab A/S's earnings last quarter? Genmab A/S (NASDAQ:GMAB) posted its quarterly earnings results on Thursday, August, 8th. ...

What time is Genmab Q2 2024 earnings conference call?

Genmab A/S (GMAB) Q2 2024 Earnings Conference Call August 8, 2024 12:00 PM ET Company Participants Jan van de Winkel - Chief Executive Officer Tahamtan Ahmadi - Chief Medical Officer Anthony Mancini -... ...

Is Genmab A/S Stock overvalued?

The company's P/E ratio of 23.58 may indicate that the stock is currently overvalued compared to its earnings, posing a risk for investors. Genmab A/S has a 1-year high of $39.81, which could signal resistance at higher price levels and limit potential short-term gains for investors. ...

How did Genmab (gmab) perform in a quarter?

Genmab A/S (NASDAQ:GMAB) posted its quarterly earnings results on Thursday, August, 8th. The company reported $0.22 EPS for the quarter, missing the consensus estimate of $0.29 by $0.07. The business had revenue of $779.50 million for the quarter, compared to analyst estimates of $734.60 million. ...

Will Genmab increase its share capital?

Company Announcement COPENHAGEN, Denmark; September 10, 2024 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 11,729 shares as a consequence of the exercise of employee warrants. The inc... ...

Where is Genmab based?

The company was founded by Donald Lee Drakeman, Florian Schonharting, and Jan G. J. van de Winkel on June 11, 1998, and is headquartered in Copenhagen, Denmark. View Genmab A/S Sponsored ADR GMAB stock quote prices, financial information, real-time forecasts, and company news from CNN. ...